Therapeutic Areas
Digital Biomarkers for Oncology Research
Accelerating Discovery
Koneksa’s digital biomarkers are bringing much-needed improvements to the speed, precision, and patient accessibility of oncology trials.
Remote digital biomarkers in oncology open the door to participation in clinical trials, even for patients dealing with the challenges of their disease and treatment side effects, including fatigue and travel-based difficulties.
With our patient-centric digital biomarker solutions and flexible, device-agnostic SaaS platform, we work with you from the design stage to ensure you get the sharp endpoints needed to stay on top of critical aspects of patient health status.
Some of the oncology areas in which we have worked in include:
Lung
Gastrointestinal
Cervical
Ecologically Valid Measures for Deeper Insights
As the leaders in digital biomarkers, Koneksa is proud to play a crucial role in the evolution of oncology trials.
Through our research experience and involvement with patient advocacy groups, we have gained a nuanced understanding of patients’ needs. That’s why our solutions are designed to capture a high volume of data obtained during patients’ everyday lives, providing crucial information about the impact of treatments while making it easier for patients to participate.
Koneksa’s oncology solutions facilitate the tracking of measures like heart rate variability (HRV), walking speed, temperature, blood pressure, and step count on a 24/7 basis, eliminating the variability introduced by performance differences in clinic versus at home, and over the course of a day.
Smarter Oncology Trials Start Here
Koneksa delivers digital biomarkers and expert support to help you capture the measures that matter—enabling faster, more accurate decisions and better outcomes for patients.
Our science-driven approach and ecologically valid measures help you understand the true impact of your treatment:
Signs, not symptoms
Digital biomarkers provide objective evidence for how patients are doing
Continuous Capabilities
Ongoing data collection allows for insights that would be impossible to glean solely from sporadic clinic visits
Progression
Frequent measures let you closely track changes in health status over time
The Data You Need, When It Matters Most
In a recent Koneksa study, daily step count predicted oncology hospitalizations—while traditional quality-of-life assessments did not. When study patients are improving—or declining—you need to know immediately.
New digital tool for oncology symptom tracking
Improve clinician-participant communication and safety monitoring
Scalable, patient-centric innovation in cancer researchMore from Koneksa
Found 6 Results
Page 2 of 2
News
Koneksa Announces Study with New York Proton Center to Collect Patient-Generated Health Data During Proton Radiotherapy in Lung Cancer
New York, NY – April 25, 2024 – Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today first patient enrolled in a pilot study collecting patient-generated health data... Download
News
Koneksa Announces New Multi-Domain Model for Functional Status Assessment Enabled by Digital Health Technologies
NEW YORK–(BUSINESS WIRE)–Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, today announced the publication of a new multi-domain model for capturing functional status in oncology through connected digital tools... Download
News
Tracking Physical Activity of Cancer Patients to Avoid Unplanned Hospitalization
Koneksa Health enables oncology research at Montefiore Einstein Center for Cancer Care by facilitating the collection and visualization of activity data from Garmin vivofit® devices. NEW YORK, NY (PRWEB)... Download
